These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25897070)

  • 1. Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings.
    Lalani M; Kaur H; Mohammed N; Mailk N; Wyk AV; Jan S; Kakar RM; Mojadidi MK; Leslie T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):51-58. PubMed ID: 25897070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi.
    Khuluza F; Kigera S; Jähnke RW; Heide L
    Malar J; 2016 Apr; 15():215. PubMed ID: 27075749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials.
    Batson JS; Bempong DK; Lukulay PH; Ranieri N; Satzger RD; Verbois L
    Malar J; 2016 Feb; 15():119. PubMed ID: 26917250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide survey of the quality of antimalarials in retail outlets in Tanzania.
    Kaur H; Goodman C; Thompson E; Thompson KA; Masanja I; Kachur SP; Abdulla S
    PLoS One; 2008; 3(10):e3403. PubMed ID: 18923672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field study.
    Visser BJ; Meerveld-Gerrits J; Kroon D; Mougoula J; Vingerling R; Bache E; Boersma J; van Vugt M; Agnandji ST; Kaur H; Grobusch MP
    Malar J; 2015 Jul; 14():273. PubMed ID: 26169915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quality of antimalarials available in Yemen.
    Abdo-Rabbo A; Bassili A; Atta H
    Malar J; 2005 Jun; 4():28. PubMed ID: 15987508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR.
    Atemnkeng MA; Chimanuka B; Plaizier-Vercammen J
    J Clin Pharm Ther; 2007 Apr; 32(2):123-32. PubMed ID: 17381662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand.
    Vijaykadga S; Cholpol S; Sitthimongkol S; Pawaphutanan A; Pinyoratanachot A; Rojanawatsirivet C; Kovithvattanapong R; Thimasarn K
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():5-10. PubMed ID: 17547041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi.
    Khuluza F; Kigera S; Heide L
    Am J Trop Med Hyg; 2017 May; 96(5):1124-1135. PubMed ID: 28219993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of the antibiotics--amoxicillin and co-trimoxazole from Ghana, Nigeria, and the United Kingdom.
    Fadeyi I; Lalani M; Mailk N; Van Wyk A; Kaur H
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):87-94. PubMed ID: 25897067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better.
    Tabernero P; Mayxay M; Culzoni MJ; Dwivedi P; Swamidoss I; Allan EL; Khanthavong M; Phonlavong C; Vilayhong C; Yeuchaixiong S; Sichanh C; Sengaloundeth S; Kaur H; Fernández FM; Green MD; Newton PN
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):95-104. PubMed ID: 25897062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and specific drug quality testing assay for artemisinin and its derivatives using a luminescent reaction and novel microfluidic technology.
    Ho NT; Desai D; Zaman MH
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):24-30. PubMed ID: 25897061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab.
    Gnegel G; Häfele-Abah C; Neci R; ; Heide L
    Sci Rep; 2022 Jul; 12(1):13095. PubMed ID: 35908047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution.
    Kayumba PC; Risha PG; Shewiyo D; Msami A; Masuki G; Ameye D; Vergote G; Ntawukuliryayo JD; Remon JP; Vervaet C
    J Clin Pharm Ther; 2004 Aug; 29(4):331-8. PubMed ID: 15271100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paper test cards for presumptive testing of very low quality antimalarial medications.
    Weaver AA; Lieberman M
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):17-23. PubMed ID: 25897064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria.
    Onwujekwe O; Kaur H; Dike N; Shu E; Uzochukwu B; Hanson K; Okoye V; Okonkwo P
    Malar J; 2009 Feb; 8():22. PubMed ID: 19208221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of simplified HPLC methods for the detection of counterfeit antimalarials in resource-restraint environments.
    Hoellein L; Holzgrabe U
    J Pharm Biomed Anal; 2014 Sep; 98():434-45. PubMed ID: 25016193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substandard anti-malarial drugs in Burkina Faso.
    Tipke M; Diallo S; Coulibaly B; Störzinger D; Hoppe-Tichy T; Sie A; Müller O
    Malar J; 2008 May; 7():95. PubMed ID: 18505584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor-quality antimalarials further health inequities in Uganda.
    Evans DR; Higgins CR; Laing SK; Awor P; Ozawa S
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii36-iii47. PubMed ID: 31816072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.